ArticleCancer immunology, immunotherapy : CII2019

An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.

Ashley Pinette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.